Clinical Trials Browser

Terminated × OTHER × Adenocarcinoma × Clear all

NCT03323944 2026-01-30

CAR T Cell Immunotherapy for Pancreatic Cancer

Phase 1 Terminated

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT01946100 2025-11-20

Treatment of Multifocal Lung Adenocarcinoma

Phase NA Terminated

Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma in Situ

NCT05161572 2025-06-18

NeoRacing

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT03840967 2024-06-04

A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma

Phase 2 Terminated

14 enrolled 11 charts

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT03997448 2024-02-20

Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149

Phase 2 Terminated

3 enrolled 10 charts

Adenocarcinoma

NCT03722108 2023-10-16

REGIRI

Phase 1/2 Terminated

Adenocarcinoma

NCT04230954 2022-06-07

Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer

Phase 2 Terminated

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT03000179 2022-04-14

Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma

Phase 2 Terminated

8 enrolled 12 charts

Adenocarcinoma

NCT02173990 2021-10-20

PULSAR

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma, Colorectal Neoplasms

NCT02404506 2021-09-29

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Phase 2 Terminated

Adenocarcinoma, Breast Neoplasms

NCT01784861 2021-07-08

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors

Phase 1/2 Terminated

23 enrolled 17 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT01206296 2021-03-09

Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma

Phase 2 Terminated

Adenocarcinoma

NCT02921737 2021-02-04

UF-STO-PANC-003

Phase 2 Terminated

7 enrolled 12 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT03407976 2020-07-15

APPEASE

Phase 1 Terminated

Adenocarcinoma, Carcinoma, Transitional Cell

NCT02487277 2020-01-02

PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

Phase 2 Terminated

3 enrolled 8 charts

Adenocarcinoma

NCT02404363 2019-07-25

PANCREADOGREL

Phase 3 Terminated

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT02271906 2019-04-30

The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting

Phase 2 Terminated

2 enrolled 8 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT00672009 2018-10-24

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Phase 2 Terminated

Adenocarcinoma, Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT01511081 2017-12-07

Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)

Phase 2 Terminated

21 enrolled 5 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Recurrence, Carcinoma, Large Cell

NCT02473094 2017-11-28

NEOMETRE

Phase 2 Terminated

Gastrointestinal

Adenocarcinoma, Carcinoma, Rectal Neoplasms

NCT01476553 2017-05-02

EIPL

Phase NA Terminated

GastrointestinalGynecologic

Adenocarcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT00127036 2017-03-23

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

Phase 2 Terminated

65 enrolled 8 charts

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Rectal Neoplasms

NCT00201734 2016-09-23

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Phase 1/2 Terminated

57 enrolled 11 charts

Adenocarcinoma, Neoplasms, Neoplasms, Unknown Primary

NCT01805908 2016-06-06

PETRA

Phase 1 Terminated

Adenocarcinoma, Breast Neoplasms, Neoplasm Metastasis

NCT02283359 2016-01-15

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Phase 1 Terminated

Gastrointestinal

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Recurrence, Stomach Neoplasms

NCT01215578 2015-04-30

NET

Phase 2 Terminated

EndocrineGastrointestinalNET

Adenocarcinoma, Adenoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

NCT00892242 2014-09-22

Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer

Phase 1 Terminated

Adenocarcinoma

NCT01365143 2014-06-02

Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy

Phase 4 Terminated

Adenocarcinoma, Prostatic Neoplasms

NCT01215565 2014-03-13

Fibrolam

Phase 2 Terminated

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pathologic Processes

NCT01096732 2014-01-08

HIPPoS

Phase 2 Terminated

Adenocarcinoma, Neoplasms

NCT01871480 2013-12-30

CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer

Phase 2 Terminated

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00368329 2012-07-16

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Phase 1 Terminated

Gastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT01363466 2011-06-01

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

Phase 3 Terminated

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous